Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
101.14
+2.22 (2.24%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Boston Scientific Stock Forecast
Stock Price Forecast
The 23 analysts with 12-month price forecasts for Boston Scientific stock have an average target of 110.26, with a low estimate of 78 and a high estimate of 130. The average target predicts an increase of 9.02% from the current stock price of 101.14.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Boston Scientific stock from 23 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 11 | 11 | 11 | 11 | 11 | 12 |
Buy | 9 | 9 | 9 | 10 | 10 | 10 |
Hold | 3 | 3 | 3 | 2 | 2 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 23 | 23 | 23 | 23 | 23 | 23 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Needham | Needham | Strong Buy Maintains $113 → $115 | Strong Buy | Maintains | $113 → $115 | +13.70% | Apr 24, 2025 |
RBC Capital | RBC Capital | Buy Maintains $116 → $120 | Buy | Maintains | $116 → $120 | +18.65% | Apr 24, 2025 |
Truist Securities | Truist Securities | Strong Buy Maintains $113 → $117 | Strong Buy | Maintains | $113 → $117 | +15.68% | Apr 24, 2025 |
Evercore ISI Group | Evercore ISI Group | Buy Maintains $110 → $112 | Buy | Maintains | $110 → $112 | +10.74% | Apr 24, 2025 |
Baird | Baird | Buy Maintains $115 → $120 | Buy | Maintains | $115 → $120 | +18.65% | Apr 24, 2025 |
Financial Forecast
Revenue This Year
19.39B
from 16.75B
Increased by 15.77%
Revenue Next Year
21.39B
from 19.39B
Increased by 10.33%
EPS This Year
2.89
from 1.25
Increased by 131.13%
EPS Next Year
3.29
from 2.89
Increased by 13.96%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 20.6B | 22.8B | 25.1B | ||
Avg | 19.4B | 21.4B | 23.5B | ||
Low | 18.6B | 20.4B | 22.3B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 23.2% | 17.6% | 17.1% | ||
Avg | 15.8% | 10.3% | 9.9% | ||
Low | 11.2% | 5.1% | 4.4% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 3.13 | 3.70 | 4.07 | ||
Avg | 2.89 | 3.29 | 3.71 | ||
Low | 2.74 | 3.10 | 3.43 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 150.3% | 27.9% | 23.7% | ||
Avg | 131.1% | 14.0% | 12.8% | ||
Low | 119.5% | 7.2% | 4.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.